Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 4

The DOI matches its Crossref record.

Gastric Carcinoma - Molecular Aspects and Current Advances

·2011
DOI 10.5772/712
Open this paper in CoChat — free account

Abstract

Gastric cancer is one of the most common tumors worldwide. It has a heterogeneous milieu, where the genetic background, tumor immunology, oxidative stress, and microbial infections are key players in the multiple stages of tumorigenesis. These diverse factors are linked to the prognosis of the gastric cancer and the survival of gastric cancer patients. This book is appropriate for scientists and students in the field of oncology, gastroenterology, molecular biology, immunology, cell biology, biology, biochemistry, and pathology. This authoritative text carefully explains the fundamentals, providing a general overview of the principles followed by more detailed explanations of these recent topics efficiently. The topics presented herein contain the most recent knowledge in gastric cancer concerning the oncogenic signaling, genetic instability, the epigenetic aspect, molecular features and their clinical implications, miRNAs, integrin and E-cadherin, carbohydrate-associated-transferases, free radicals, immune cell responses, mucins, Helicobacter-pylori, neoadjuvant and adjuvant therapy, prophylactic strategy for peritoneal recurrence, and hepatic metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5772/712

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 1027

  1. Baeuerle, P. A., & Baltimore, D. (1996). NF-kappa B: ten years after. Cell, 87(1), 13-20.
  2. Balemans, W., & Van Hul, W. (2002). Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol, 250(2), 231-250.
  3. Barnes, P. J., & Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med, 336(15), 1066-1071.
  4. Behrens, M.E., Grandgenett, P.M., Bailey, J.M, Singh, P.K., Yi, C.H., Yu, F. & Hollingsworth M.A. (2010). The reactive tumor microenvironment: MUC1 signaling directly reprograms transciption of CTGF. Oncogene, 29(42), 5667-5677.
  5. Blobe, G.C., Schiemann, W.P., & Lodish, H.F. (2000). Role of transforming growth factor-β in human disease. N Engl J Med, 342(3), 1350-1358.
  6. Li, M., Eriksen, E.F., & Bunger, C. (1996). Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone, 18(1), 53-57
  7. Li, Q., & Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat Rev Immunol, 2(10), 725-734.
  8. Li, Q.L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X.Z., Lee, K.Y., Nomura, S., Lee, C.W., Han, S.B., Kim, H.M., Kim, W.J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S.C., & Ito, Y. (2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 109(1), 113-124.
  9. Liang, B., Wang, S., Zhu, X.G., Yu, Y.X., Cui, Z.R., & Yu, Y.Z. (2005). Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol, 11(5),623-8.
  10. Liu, L., Ning, X., Sun, L., Zhang, H., Shi, Y., Guo, C., Han, S., Liu, J., Sun, S., Han, Z., Wu, K., & Fan, D. (2008). Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci, 99(1), 121-128.
  11. Liu, X., Wang, X., Zhang, J., Lam, E. K., Shin, V. Y., Cheng, A. S., Yu, J., Chan, F. K., Sung, J. J., & Jin, H. C. (2010). Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene, 29(3), 442-450.
  12. Maehara, Y., Kakeji, Y., Kabashima, A., Emi, Y., Watanabe, A., Akazawa, K., Baba, H., Kohnoe, S., & Sugimachi K. (1999). Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol, 17(2), 607-614.
  13. Massagué, J. (1996). TGF-beta signaling: receptors, transducers, and mad proteins. Cell, 85(7), 947-950.
  14. Sasaki, N., Morisaki, T., Hashizume, K., Yao, T., Tsuneyoshi, M., Noshiro, H., Nakamura, K., Yamanaka, T., Uchiyama, A., Tanaka, M., & Katano, M. (2001). Nuclear factor- kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res, 7(12), 4136-4142.
  15. Schuller, H.M., Kabalka, G., Smith, G., Mereddy, A., Akula, M., & Cekanova, M. (2006) Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention. Chem Med Chem, 1(6), 603-610.
  16. Seno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., & Taketo, M. M. (2002). Cyclooxygenase-2 and prostaglandin E2 receptor EP2- dependent angiogenesis in Apc_716 mouse intestinal polyps. Cancer Res, 62(2), 506- 511.
  17. Shi, Y., & Massagué, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113(6), 685-700.
  18. Siegel, P. M. & Massagué, J. (2003). Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer, 3(11), 807-821.
  19. Silva, F., Carvalho, F., Peixoto, A., Seixas, M., Almeida, R., Carneiro, F., Mesquita, P., Figueiredo, C., Nogueira, C., Swallow, D.M., Amorim, A., & David, L. (2001). MUC1 gene polymorphism in the gastric carcinogenesis pathway. Eur J Hum Genet, 9(7), 548-552.
  20. Singh, P.K., & Hollingsworth, M.A. (2006). Cell surface-associated mucins in signal transduction. Trends Cell Biol, 16(9),467-76.
  21. Smith, M.F.Jr., Mitchell, A., Li, G. Ding, G., Fitzmaurice, A.M., Ryan, K., Crowe, S., & Goldberg J.B. (2003). Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are independently predicts gastric cancer patient survival. Br J Cancer, 101, (6), pp. 1011-1018, ISSN 1532-1827
  22. Blasi, M. F., Ventura, I., Aquilina, G., Degan, P., Bertario, L., Bassi, C., Radice, P. & Bignami, M. (2006). A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res, 66, (18), pp. 9036-9044, ISSN 0008-5472
  23. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N. & Srivastava, S. (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res, 58, (22), pp. 5248-5257, ISSN 0008-5472
  24. Boland, C. R. & Goel, A. (2010). Microsatellite instability in colorectal cancer. Gastroenterology, 138, (6), pp. 2073-2087 e2073, ISSN 1528-0012
  25. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R. & Dvorak, H. F. (1993). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 53, (19), pp. 4727-4735, ISSN 0008-5472
  26. Buermeyer, A. B., Deschenes, S. M., Baker, S. M. & Liskay, R. M. (1999). Mammalian DNA mismatch repair. Annu Rev Genet, 33, pp. 533-564, ISSN 0066-4197
  27. Buffart, T. E., Carvalho, B., Hopmans, E., Brehm, V., Kranenbarg, E. K., Schaaij-Visser, T. B., Eijk, P. P., van Grieken, N. C., Ylstra, B., van de Velde, C. J. & Meijer, G. A. (2007a). Gastric cancers in young and elderly patients show different genomic profiles. J Pathol, 211, (1), pp. 45-51, ISSN 0022-3417
  28. Buffart, T. E., Carvalho, B., Mons, T., Reis, R. M., Moutinho, C., Silva, P., van Grieken, N. C., Vieth, M., Stolte, M., van de Velde, C. J., Schrock, E., Matthaei, A., Ylstra, B., Carneiro, F. & Meijer, G. A. (2007b). DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics, 8, pp. 345, ISSN 1471-2164
  29. Buffart, T. E., Louw, M., van Grieken, N. C., Tijssen, M., Carvalho, B., Ylstra, B., Grabsch, H., Mulder, C. J., van de Velde, C. J., van der Merwe, S. W. & Meijer, G. A. (2011). Gastric cancers of Western European and African patients show different patterns of genomic instability. BMC Med Genomics, 4, pp. 7, ISSN 1755-8794
  30. Buhard, O., Suraweera, N., Lectard, A., Duval, A. & Hamelin, R. (2004). Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers, 20, (4-5), pp. 251-257, ISSN 0278-0240
  31. Buhard, O., Cattaneo, F., Wong, Y. F., Yim, S. F., Friedman, E., Flejou, J. F., Duval, A. & Hamelin, R. (2006). Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol, 24, (2), pp. 241-251, ISSN 1527-7755
  32. Caca, K., Kolligs, F. T., Ji, X., Hayes, M., Qian, J., Yahanda, A., Rimm, D. L., Costa, J. & Fearon, E. R. (1999). Beta-and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional imbalance of 8p indicates poor survival in gastric cancer. J Mol Diagn, 6, (3), pp. 243-252, ISSN 1525-1578
  33. Garcia, I., del Casar, J. M., Corte, M. D., Allende, M. T., Garcia-Muniz, J. L. & Vizoso, F. (2003). Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. Int J Biol Markers, 18, (3), pp. 200-206, ISSN 0393- 6155
  34. Gazvoda, B., Juvan, R., Zupanic-Pajnic, I., Repse, S., Ferlan-Marolt, K., Balazic, J. & Komel, R. (2007). Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA. Eur J Gastroenterol Hepatol, 19, (12), pp. 1082-1089
  35. Gollin, S. M. (2005). Mechanisms leading to chromosomal instability. Semin Cancer Biol, 15, (1), pp. 33-42
  36. Grabsch, H. I., Askham, J. M., Morrison, E. E., Pomjanski, N., Lickvers, K., Parsons, W. J., Boecking, A., Gabbert, H. E. & Mueller, W. (2004). Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability. J Pathol, 202, (2), pp. 208-214, ISSN 0022-3417
  37. Gu, M., Kim, D., Bae, Y., Choi, J., Kim, S. & Song, S. (2009). Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas. Hepatogastroenterology, 56, (91-92), pp. 899-904, ISSN 0172- 6390
  38. Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A. & Reeve, A. E. (1998). E-cadherin germline mutations in familial gastric cancer. Nature, 392, (6674), pp. 402-405, ISSN 0028-0836
  39. Guerrette, S., Acharya, S. & Fishel, R. (1999). The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem, 274, (10), pp. 6336-6341, ISSN 0021-9258
  40. Gylling, A., Abdel-Rahman, W. M., Juhola, M., Nuorva, K., Hautala, E., Jarvinen, H. J., Mecklin, J. P., Aarnio, M. & Peltomaki, P. (2007). Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut, 56, (7), pp. 926-933, ISSN 0017-5749
  41. Hamilton, J. P. & Meltzer, S. J. (2006). A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol, 4, (4), pp. 416-425, ISSN 1542-3565
  42. Hara, T., Ooi, A., Kobayashi, M., Mai, M., Yanagihara, K. & Nakanishi, I. (1998). Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest, 78, (9), pp. 1143-1153, ISSN 0023-6837
  43. Hattori, Y., Itoh, H., Uchino, S., Hosokawa, K., Ochiai, A., Ino, Y., Ishii, H., Sakamoto, H., Yamaguchi, N., Yanagihara, K., Hirohashi, S., Sugimura, T. & Terada, M. (1996). Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res, 2, (8), pp. 1373-1381, ISSN 1078-0432
  44. Hirohashi, S. & Sugimura, T. (1991). Genetic alterations in human gastric cancer. Cancer Cells, 3, (2), pp. 49-52, ISSN 1042-2196
  45. Hiyama, T., Haruma, K., Kitadai, Y., Masuda, H., Miyamoto, M., Tanaka, S., Yoshihara, M., Shimamoto, F. & Chayama, K. (2002). K-ras mutation in helicobacter pylori- associated chronic gastritis in patients with and without gastric cancer. Int J Cancer, 97, (5), pp. 562-566, ISSN 0020-7136
  46. Hong, S. J., Jeon, E. J., Oh, J. H., Seo, E. J., Choi, S. W. & Rhyu, M. G. (2010). The gene- reduction effect of chromosomal losses detected in gastric cancers. BMC Gastroenterol, 10, pp. 138
  47. Hou, Q., Wu, Y. H., Grabsch, H., Zhu, Y., Leong, S. H., Ganesan, K., Cross, D., Tan, L. K., Tao, J., Gopalakrishnan, V., Tang, B. L., Kon, O. L. & Tan, P. (2008). Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res, 68, (12), pp. 4623-4630, ISSN 1538-7445
  48. Hudler, P., Vouk, K., Liovic, M., Repse, S., Juvan, R. & Komel, R. (2004). Mutations in the hMLH1 gene in Slovenian patients with gastric carcinoma. Clin Genet, 65, (5), pp. 405-411
  49. Hudler, P., Kastelic, S., Frkovic-Grazio, S. & Komel, R. (2009). Polymorphisms in AURKA gene in Slovenian patients with gastric cancer. (Preliminary report). Proceedings of Joint Congress of the Slovenian Biochemical Society and the Genetic Society of Slovenia with International Participation, Otocec, September, 2009
  50. Hudler, P., Simic, M., Frkovic-Grazio, S. & Komel, R. (2010). Polymorphisms in TTK and BUB1B genes in Slovenian patients with gastric cancer. (Preliminary report). Proceedings of 5 th CFGBC Symposium, Ljubljana, June 2010
  51. Imai, K. & Yamamoto, H. (2008). Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis, 29, (4), pp. 673- 680, ISSN 1460-2180
  52. Iovino, F., Lentini, L., Amato, A. & Di Leonardo, A. (2006). RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol Cancer, 5, pp. 38, ISSN 1476-4598
  53. Jiaqing, L., Hokita, S., Xiangming, C., Natsugoe, S., Tanabe, G., Baba, M., Takao, S. & Aikou, T. (1998). Role of cyclin E and p53 expression in progression of early gastric cancer. Gastric Cancer, 1, (2), pp. 160-165, ISSN 1436-3291
  54. Junnila, S., Kokkola, A., Karjalainen-Lindsberg, M. L., Puolakkainen, P. & Monni, O. (2010). Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines. BMC Cancer, 10, pp. 73, ISSN 1471-2407
  55. Juvan, R., Hudler, P., Gazvoda, B., Repse, S., Bracko, M. & Komel, R. (2007). Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma. Croat Med J, 48, (2), pp. 207-217, ISSN 1332-8166
  56. Kanai, Y. & Hirohashi, S. (1997). Invasion and metastasis, In: Gastric cancer, T. Sugimura, pp. 109, Oxford University Press, Oxford.
  57. Kang, J. U., Kang, J. J., Kwon, K. C., Park, J. W., Jeong, T. E., Noh, S. M. & Koo, S. H. (2006). Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J Korean Med Sci, 21, (4), pp. 656-665, ISSN 1011-8934
  58. Kim, H. S., Lee, B. L., Woo, D. K., Bae, S. I. & Kim, W. H. (2001). Assessment of markers for the identification of microsatellite instability phenotype in gastric neoplasms. Cancer Lett, 164, (1), pp. 61-68, ISSN 0304-3835
  59. Kim, J. H., Takahashi, T., Chiba, I., Park, J. G., Birrer, M. J., Roh, J. K., De Lee, H., Kim, J. P., Minna, J. D. & Gazdar, A. F. (1991). Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst, 83, (13), pp. 938-943
  60. Kimura, Y., Noguchi, T., Kawahara, K., Kashima, K., Daa, T. & Yokoyama, S. (2004). Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol, 17, (11), pp. 1328-1337, ISSN 0893-3952
  61. Kinzler, K. W., Nilbert, M. C., Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D. & et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science, 253, (5020), pp. 661-665, ISSN 0036- 8075
  62. Knudson, A. G. (1993). Antioncogenes and human cancer. Proc Natl Acad Sci U S A, 90, (23), pp. 10914-10921, ISSN 0027-8424
  63. Kondo, T., Oue, N., Mitani, Y., Kuniyasu, H., Noguchi, T., Kuraoka, K., Nakayama, H. & Yasui, W. (2005). Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene, 24, (1), pp. 157-164, ISSN 0950-9232
  64. Kondo, E., Suzuki, H., Horii, A. & Fukushige, S. (2003). A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res, 63, (12), pp. 3302-3308, ISSN 0008-5472
  65. Koo, S. H., Jeong, T. E., Kang, J., Kwon, K. C., Park, J. W. & Noh, S. M. (2004). Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Cancer Genet Cytogenet, 153, (1), pp. 26- 31, ISSN 0165-4608
  66. Kumar, P., Henikoff, S. & Ng, P. C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc, 4, (7), pp. 1073- 1081
  67. Lawes, D. A., SenGupta, S. & Boulos, P. B. (2003). The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol, 29, (3), pp. 201-212, ISSN 0748-7983
  68. Lazar, D., Taban, S., Sporea, I., Dema, A., Cornianu, M., Lazar, E., Goldis, A., Ratiu, I. & Vernic, C. (2010). The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients. Rom J Morphol Embryol, 51, (2), pp. 249-257, ISSN 1220-0522
  69. Leite, M., Corso, G., Sousa, S., Milanezi, F., Afonso, L. P., Henrique, R., Soares, J. M., Castedo, S., Carneiro, F., Roviello, F., Oliveira, C. & Seruca, R. (2011). MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer, 128, (7), pp. 1606-1613, ISSN 1097-0215
  70. Leung, S. Y., Yuen, S. T., Chung, L. P., Chu, K. M., Chan, A. S. & Ho, J. C. (1999). hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res, 59, (1), pp. 159-164, ISSN 0008-5472
  71. Liu, X. P., Tsushimi, K., Tsushimi, M., Oga, A., Kawauchi, S., Furuya, T. & Sasaki, K. (2001). Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma. Pathol Int, 51, (6), pp. 440-444
  72. Loeb, L. A. (2001). A mutator phenotype in cancer. Cancer Res, 61, (8), pp. 3230-3239, ISSN 0008-5472
  73. Ou, J., Niessen, R. C., Lutzen, A., Sijmons, R. H., Kleibeuker, J. H., de Wind, N., Rasmussen, L. J. & Hofstra, R. M. (2007). Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes. Hum Mutat, 28, (11), pp. 1047-1054, ISSN 1098-1004
  74. Oue, N., Sentani, K., Yokozaki, H., Kitadai, Y., Ito, R. & Yasui, W. (2001). Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Pathobiology, 69, (3), pp. 143-149, ISSN 1015- 2008
  75. Panani, A. D. (2008). Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett, 266, (2), pp. 99-115, ISSN 0304-3835
  76. Park, W. S., Oh, R. R., Park, J. Y., Lee, S. H., Shin, M. S., Kim, Y. S., Kim, S. Y., Lee, H. K., Kim, P. J., Oh, S. T., Yoo, N. J. & Lee, J. Y. (1999). Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res, 59, (17), pp. 4257- 4260, ISSN 0008-5472
  77. Pedrazzani, C., Corso, G., Velho, S., Leite, M., Pascale, V., Bettarini, F., Marrelli, D., Seruca, R. & Roviello, F. (2009). Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer, 8, (3), pp. 215-220, ISSN 1573-7292
  78. Pellegata, N. S., Losekoot, M., Fodde, R., Pugliese, V., Saccomanno, S., Renault, B., Bernini, L. F. & Ranzani, G. N. (1992). Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Anticancer Res, 12, (5), pp. 1731-1735, ISSN 0250-7005
  79. Perera, S. & Bapat, B. (2008). The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation. Hum Mutat, 29, (2), pp. 332, ISSN 1098-1004
  80. Percesepe, A., Borghi, F., Menigatti, M., Losi, L., Foroni, M., Di Gregorio, C., Rossi, G., Pedroni, M., Sala, E., Vaccina, F., Roncucci, L., Benatti, P., Viel, A., Genuardi, M., Marra, G., Kristo, P., Peltomaki, P. & Ponz de Leon, M. (2001). Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol, 19, (19), pp. 3944-3950
  81. Perucho, M. (1996). Microsatellite instability: the mutator that mutates the other mutator. Nat Med, 2, (6), pp. 630-631, ISSN 1078-8956
  82. Pino, M. S. & Chung, D. C. (2010). The chromosomal instability pathway in colon cancer. Gastroenterology, 138, (6), pp. 2059-2072, ISSN 1528-0012
  83. Rajcevic, U., Hudler, P., Mijovski, G., Gorjanc, G., Hoelzl, G., Repse, S., Juvan, R., Kovac, M., Huber, C. G. & Komel, R. (2007). Assessment of differential expression of oncogenes in adenocarcinoma of stomach with fluorescent labeling and simultaneous amplification of gene transcripts. Radiol Oncol, 41, (4), pp. 174-182
  84. Raevaara, T. E., Korhonen, M. K., Lohi, H., Hampel, H., Lynch, E., Lonnqvist, K. E., Holinski-Feder, E., Sutter, C., McKinnon, W., Duraisamy, S., Gerdes, A. M., Peltomaki, P., Kohonen-Ccorish, M., Mangold, E., Macrae, F., Greenblatt, M., de la Chapelle, A. & Nystrom, M. (2005). Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology, 129, (2), pp. 537-549, ISSN 0016-5085
  85. Ramensky, V., Bork, P. & Sunyaev, S. (2002). Human non-synonymous SNPs: server and survey. Nucleic Acids Res, 30, (17), pp. 3894-3900, ISSN 1362-4962
  86. Resende, C., Ristimaki, A. & Machado, J. C. (2010). Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter, 15 Suppl 1, pp. 34-39, ISSN 1523-5378
  87. Ricke, R. M., van Ree, J. H. & van Deursen, J. M. (2008). Whole chromosome instability and cancer: a complex relationship. Trends Genet, 24, (9), pp. 457-466, ISSN 0168-9525
  88. Russo, A., Bazan, V., Migliavacca, M., Zanna, I., Tubiolo, C., Tumminello, F. M., Dardanoni, G., Cajozzo, M., Bazan, P., Modica, G., Latteri, M., Tomasino, R. M., Colucci, G., Gebbia, N. & Leto, G. (2000). Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Clin Cancer Res, 6, (1), pp. 178-184, ISSN 1078-0432
  89. Samowitz, W. S., Curtin, K., Lin, H. H., Robertson, M. A., Schaffer, D., Nichols, M., Gruenthal, K., Leppert, M. F. & Slattery, M. L. (2001). The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology, 121, (4), pp. 830-838, ISSN 0016-5085
  90. Scartozzi, M., Galizia, E., Freddari, F., Berardi, R., Cellerino, R. & Cascinu, S. (2004). Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev, 30, (5), pp. 451-459, ISSN 0305-7372
  91. Schmit, T. L. & Ahmad, N. (2007). Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol Cancer Ther, 6, (7), pp. 1920-1931, ISSN 1535-7163
  92. Schneider, B. G., Bravo, J. C., Roa, J. C., Roa, I., Kim, M. C., Lee, K. M., Plaisance, K. T., Jr., McBride, C. M. & Mera, R. (2000). Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer, 89, (5), pp. 444-452, ISSN 0020-7136
  93. Schneider, B. G., Peng, D. F., Camargo, M. C., Piazuelo, M. B., Sicinschi, L. A., Mera, R., Romero-Gallo, J., Delgado, A. G., Bravo, L. E., Wilson, K. T., Peek, R. M., Jr., Correa, P. & El-Rifai, W. (2010). Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer, 127, (11), pp. 2588-2597, ISSN 1097-0215
  94. Sharp, A., Pichert, G., Lucassen, A. & Eccles, D. (2004). RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1. Hum Mutat, 24, (3), pp. 272, ISSN 1098-1004
  95. Shepard, J. L., Amatruda, J. F., Finkelstein, D., Ziai, J., Finley, K. R., Stern, H. M., Chiang, K., Hersey, C., Barut, B., Freeman, J. L., Lee, C., Glickman, J. N., Kutok, J. L., Aster, J. C. & Zon, L. I. (2007). A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev, 21, (1), pp. 55-59
  96. Shimodaira, H., Filosi, N., Shibata, H., Suzuki, T., Radice, P., Kanamaru, R., Friend, S. H., Kolodner, R. D. & Ishioka, C. (1998). Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet, 19, (4), pp. 384-389
  97. Simpson, A. J., Caballero, O. L. & Pena, S. D. (2001). Microsatellite instability as a tool for the classification of gastric cancer. Trends Mol Med, 7, (2), pp. 76-80, ISSN 1471-4914
  98. Smith, M. G., Hold, G. L., Tahara, E. & El-Omar, E. M. (2006). Cellular and molecular aspects of gastric cancer. World J Gastroenterol, 12, (19), pp. 2979-2990
  99. Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., Christensen, J. G., Settleman, J. & Haber, D. A. (2006). Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A, 103, (7), pp. 2316-2321, ISSN 0027-8424
  100. Soh, K., Yanagisawa, A., Hiratsuka, H., Sugano, H. & Kato, Y. (1993). Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res, 84, (4), pp. 388-393, ISSN 0910-5050
  101. Suraweera, N., Duval, A., Reperant, M., Vaury, C., Furlan, D., Leroy, K., Seruca, R., Iacopetta, B. & Hamelin, R. (2002). Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology, 123, (6), pp. 1804-1811, ISSN 0016-5085
  102. Suzuki, K., Ohnami, S., Tanabe, C., Sasaki, H., Yasuda, J., Katai, H., Yoshimura, K., Terada, M., Perucho, M. & Yoshida, T. (2003). The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancer. Gastroenterology, 125, (5), pp. 1330-1340, ISSN 0016-5085
  103. Suzuki, K., Suzuki, I., Leodolter, A., Alonso, S., Horiuchi, S., Yamashita, K. & Perucho, M. (2006). Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell, 9, (3), pp. 199-207
  104. Tahara, E. (1995). Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer, 75, (6 Suppl), pp. 1410-1417
  105. Tahara, E. (2004). Genetic pathways of two types of gastric cancer. IARC Sci Publ, (157), pp. 327-349
  106. Tahara, E. (2008). Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron, 1, (1), pp. 85-91, ISSN 1875-2292
  107. Takahashi, M., Shimodaira, H., Andreutti-Zaugg, C., Iggo, R., Kolodner, R. D. & Ishioka, C. (2007). Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res, 67, (10), pp. 4595-4604, ISSN 0008-5472
  108. Tamura, G. (2006). Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol, 12, (2), pp. 192-198
  109. Tavtigian, S. V., Greenblatt, M. S., Lesueur, F. & Byrnes, G. B. (2008). In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat, 29, (11), pp. 1327-1336, ISSN 1098-1004
  110. Tian, X., Song, S., Wu, J., Meng, L., Dong, Z. & Shou, C. (2001). Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun, 286, (3), pp. 505-512
  111. Tomonaga, T. & Nomura, F. (2007). Chromosome instability and kinetochore dysfunction. Histol Histopathol, 22, (2), pp. 191-197
  112. Tournier, I., Vezain, M., Martins, A., Charbonnier, F., Baert-Desurmont, S., Olschwang, S., Wang, Q., Buisine, M. P., Soret, J., Tazi, J., Frebourg, T. & Tosi, M. (2008). A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat, 29, (12), pp. 1412-1424
  113. Weiss, M. M., Kuipers, E. J., Postma, C., Snijders, A. M., Pinkel, D., Meuwissen, S. G., Albertson, D. & Meijer, G. A. (2004). Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol, 26, (5-6), pp. 307-317, ISSN 1570-5870
  114. Werner, M., Becker, K. F., Keller, G. & Hofler, H. (2001). Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol, 127, (4), pp. 207-216, ISSN 0171-5216
  115. Wright, P. A. & Williams, G. T. (1993). Molecular biology and gastric carcinoma. Gut, 34, (2), pp. 145-147, ISSN 0017-5749
  116. Wu, C. W., Chen, G. D., Fann, C. S., Lee, A. F., Chi, C. W., Liu, J. M., Weier, U. & Chen, J. Y. (2002). Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer, 35, (3), pp. 219-231, ISSN 1045-2257
  117. Wu, M. S., Lee, C. W., Shun, C. T., Wang, H. P., Lee, W. J., Chang, M. C., Sheu, J. C. & Lin, J. T. (2000). Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer, 27, (4), pp. 403-411, ISSN 1045-2257
  118. Wu, W. K., Cho, C. H., Lee, C. W., Fan, D., Wu, K., Yu, J. & Sung, J. J. (2010). Dysregulation of cellular signaling in gastric cancer. Cancer Lett, 295, (2), pp. 144-153, ISSN 1872- 7980
  119. Xiangming, C., Hokita, S., Natsugoe, S., Tanabe, G., Baba, M., Takao, S., Kuroshima, K. & Aikou, T. (1999). Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology, 57, (2), pp. 131-137, ISSN 0030-2414
  120. Xiangming, C., Natsugoe, S., Takao, S., Hokita, S., Tanabe, G., Baba, M., Kuroshima, K. & Aikou, T. (2000). The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma. Cancer, 89, (6), pp. 1214-1219
  121. Yamamoto, E., Suzuki, H., Takamaru, H., Yamamoto, H., Toyota, M. & Shinomura, Y. (2011). Role of DNA Methylation in the Development of Diffuse-Type Gastric Cancer. Digestion, 83, (4), pp. 241-249, ISSN 1421-9867
  122. Yamamoto, H., Perez-Piteira, J., Yoshida, T., Terada, M., Itoh, F., Imai, K. & Perucho, M. (1999). Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology, 116, (6), pp. 1348-1357, ISSN 0016-5085
  123. Yamamoto, S., Yasui, W., Kitadai, Y., Yokozaki, H., Haruma, K., Kajiyama, G. & Tahara, E. (1998). Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int, 48, (7), pp. 499-506, ISSN 1320-5463
  124. Yamashita, K., Sakuramoto, S. & Watanabe, M. (2011). Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today, 41, (1), pp. 24-38, ISSN 1436-2813
  125. Yasa, M. H., Bektas, A., Yukselen, V., Akbulut, H., Camci, C. & Ormeci, N. (2005). DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions. Int J Clin Pract, 59, (9), pp. 1029-1033, ISSN 1368-5031
  126. Yasui, W., Tahara, E., Tahara, H., Fujimoto, J., Naka, K., Nakayama, J., Ishikawa, F. & Ide, T. (1999). Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach. Jpn J Cancer Res, 90, (6), pp. 589-595, ISSN 0910-5050
  127. Yokozaki, H., Yasui, W. & Tahara, E. (2001). Genetic and epigenetic changes in stomach cancer. Int Rev Cytol, 204, pp. 49-95, ISSN 0074-7696
  128. Yonemura, Y., Takamura, H., Ninomiya, I., Fushida, S., Tsugawa, K., Kaji, M., Nakai, Y., Ohoyama, S., Yamaguchi, A. & Miyazaki, I. (1992). Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. Oncology, 49, (2), pp. 157-161, ISSN 0030-2414
  129. Yoshida, K., Yasui, W., Ito, H. & Tahara, E. (1990). Growth factors in progression of human esophageal and gastric carcinomas. Exp Pathol, 40, (4), pp. 291-300, ISSN 0232-1513
  130. Zhang, X. L., Yang, Y. S., Xu, D. P., Qu, J. H., Guo, M. Z., Gong, Y. & Huang, J. (2009). Comparative study on overexpression of HER2/neu and HER3 in gastric cancer. World J Surg, 33, (10), pp. 2112-2118, ISSN 1432-2323
  131. Zheng, L., Wang, L., Ajani, J. & Xie, K. (2004). Molecular basis of gastric cancer development and progression. Gastric Cancer, 7, (2), pp. 61-77
  132. Zhou, X. P., Hoang, J. M., Li, Y. J., Seruca, R., Carneiro, F., Sobrinho-Simoes, M., Lothe, R. A., Gleeson, C. M., Russell, S. E., Muzeau, F., Flejou, J. F., Hoang-Xuan, K., Lidereau, R., Thomas, G. & Hamelin, R. (1998). Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer, 21, (2), pp. 101-107, ISSN 1045-2257
  133. Zhou, Y., Li, N., Zhuang, W. & Wu, X. (2011). Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a chinese han population. Mol Carcinog, 50, (3), pp. 184-188, ISSN 1098-2744
  134. Zwick, A., Munir, M., Ryan, C. K., Gian, J., Burt, R. W., Leppert, M., Spirio, L. & Chey, W. Y. (1997). Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology, 113, (2), pp. 659-663, ISSN 0016-5085
  135. Belien JA, Buffart TE, Gill AJ, et al.: Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. Br J Cancer 2009;101:1011-1018.
  136. Nardone G: Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther 2003;17 Suppl 2:75-81.
  137. Yamamoto H, Imai K, Perucho M: Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J Gastroenterol 2002;37:153-163.
  138. Zhang D, Wang Z, Luo Y, et al.: Analysis of DNA copy number aberrations by multiple ligation-dependent probe amplification on 50 intestinal type gastric cancers. J Surg Oncol;103:124-132.
  139. Dittmar Y, Posorski N, Rauchfuss F, et al.: Relationship between degree of chromosomal aberration and survival in intestinal-type gastric cancer -a preliminary report based on three cases of hepatic metastasized gastric cancer with long-time survival. Onkologie;33:591-596.
  140. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998;396:643-649.
  141. Zeng J, Ge Z, Wang L, et al.: The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology;138:981-992.
  142. Carneiro F, Oliveira C, Seruca R: Pathology and genetics of familial gastric cancer. Int J Surg Pathol;18:33S-36S.
  143. Wolf EM, Geigl JB, Svrcek M, et al.: [Hereditary gastric cancer]. Pathologe;31:423-429.
  144. Leite M, Corso G, Sousa S, et al.: MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer;128:1606-1613.
  145. Caldas C, Carneiro F, Lynch HT, et al.: Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873-880.
  146. Capelle LG, Van Grieken NC, Lingsma HF, et al.: Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology;138:487-492.
  147. Varley JM: Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003;21:313-320.
  148. Evans DG, Wu CL, Birch JM: BRCA2: a cause of Li-Fraumeni-like syndrome. J Med Genet 2008;45:62-63.
  149. Wu WK, Cho CH, Lee CW, et al.: Dysregulation of cellular signaling in gastric cancer. Cancer Lett;295:144-153.
  150. Gravalos C, Jimeno A: HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008;19:1523-1529.
  151. Meza-Junco J, Au HJ, Sawyer MB: Trastuzumab for gastric cancer. Expert Opin Biol Ther 2009;9:1543-1551.
  152. Bianco R, Garofalo S, Rosa R, et al.: Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti- EGFR drugs. Br J Cancer 2008;98:923-930.
  153. Wu M, Semba S, Oue N, et al.: BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 2004;7:246-253.
  154. Waldner MJ, Neurath MF: The molecular therapy of colorectal cancer. Mol Aspects Med;31:171-178.
  155. Iwasaki J, Nihira S: Anti-angiogenic therapy against gastrointestinal tract cancers. Jpn J Clin Oncol 2009;39:543-551.
  156. Lesko E, Majka M: The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 2008;13:1271-1280.
  157. Trusolino L, Bertotti A, Comoglio PM: MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol;11:834-848.
  158. Amemiya H, Kono K, Takahashi A, et al.: c-Met expression in a gastric cancer cell line producing alpha-fetoprotein. Surg Today 2004;34:115-122.
  159. Kuniyasu H, Yasui W, Kitadai Y, et al.: Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189:227-232.
  160. Arkenau HT: Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol 2009;135:855-866.
  161. Ming SC: Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review. Gastric Cancer 1998;1:31-50.
  162. Hattori Y, Itoh H, Uchino S, et al.: Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 1996;2:1373-1381.
  163. Suzuki S, Dobashi Y, Hatakeyama Y, et al.: Clinicopathological significance of platelet- derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-beta phosphorylation, and microvessel density in gastric cancer. BMC Cancer;10:659.
  164. Caruso R, Pallone F, Fina D, et al.: Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 2006;169:268-278.
  165. Hu T, Li C: Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer;9:236.
  166. Tahara E: Molecular biology of gastric cancer. World J Surg 1995;19:484-488; discussion 489-490.
  167. Takahashi-Yanaga F, Sasaguri T: Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 2009;109:179-183.
  168. Yang L, Xie G, Fan Q, Xie J: Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene;29:469-481.
  169. Lee SY, Han HS, Lee KY, et al.: Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncol Rep 2007;17:1051-1055.
  170. Borggrefe T, Oswald F: The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009;66:1631-1646.
  171. Iso T, Kedes L, Hamamori Y: HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003;194:237-255.
  172. Fischer A, Gessler M: Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007;35:4583-4596.
  173. Satoh Y, Matsumura I, Tanaka H, et al.: Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem 2004;279:24986-24993.
  174. Palomero T, Lim WK, Odom DT, et al.: NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006;103:18261-18266.
  175. Ronchini C, Capobianco AJ: Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 2001;21:5925-5934.
  176. Deftos ML, He YW, Ojala EW, Bevan MJ: Correlating notch signaling with thymocyte maturation. Immunity 1998;9:777-786.
  177. Mishra L, Derynck R, Mishra B: Transforming growth factor-beta signaling in stem cells and cancer. Science 2005;310:68-71.
  178. Miyazono K, Suzuki H, Imamura T: Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 2003;94:230-234.
  179. Kim YI, Lee HJ, Khang I, et al.: Selective inhibition of cell growth by activin in SNU-16 cells. World J Gastroenterol 2006;12:3000-3005.
  180. Shinto O, Yashiro M, Kawajiri H, et al.: Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer;102:844-851.
  181. Kawajiri H, Yashiro M, Shinto O, et al.: A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 2008;14:2850-2860.
  182. O'Connor PM: Mammalian G1 and G2 phase checkpoints. Cancer Surv 1997;29:151- 182.
  183. Schwartz GK, Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005;23:9408-9421.
  184. Boonstra J: Progression through the G1-phase of the on-going cell cycle. J Cell Biochem 2003;90:244-252.
  185. Akama Y, Yasui W, Yokozaki H, et al.: Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995;86:617-621.
  186. Menendez D, Inga A, Resnick MA: The expanding universe of p53 targets. Nat Rev Cancer 2009;9:724-737.
  187. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A: TP53 and gastric carcinoma: a review. Hum Mutat 2003;21:258-270.
  188. Yasui W, Akama Y, Kuniyasu H, et al.: Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol 1996;180:122-128.
  189. Le TV, Seo Y, Ryu CJ, et al.: Increased expression of p27 is associated with the cisplatin resistance in gastric cancer cell line YCC-3. Arch Pharm Res;33:1127-1132.
  190. Schneider G, Kramer OH: NFkappaB/p53 crosstalk-a promising new therapeutic target. Biochim Biophys Acta;1815:90-103.
  191. Liu CA, Wang MJ, Chi CW, et al.: Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene 2004;23:8731-8742.
  192. Cho SJ, Park JW, Kang JS, et al.: Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression. Cancer Sci 2008;99:1117-1124.
  193. Yoon CS, Hyung WJ, Lee JH, et al.: Expression of S100A4, E-cadherin, alpha-and beta- catenin in gastric adenocarcinoma. Hepatogastroenterology 2008;55:1916-1920.
  194. Huang HL, Wu BY, Zhu XD, et al.: [Expression of S100A6 in primary and metastatic human gastric cancer]. Zhonghua Zhong Liu Za Zhi 2008;30:506-510.
  195. Boye K, Maelandsmo GM: S100A4 and metastasis: a small actor playing many roles. Am J Pathol;176:528-535.
  196. Ning X, Sun S, Hong L, et al.: Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 2007;5:1254-1262.
  197. Fackenthal JD, Olopade OI: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007;7:937-948.
  198. Liang Y, Lin SY, Brunicardi FC, et al.: DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 2009;33:661-666.
  199. Huang YQ, Yuan Y, Ge WT, et al.: Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients. J Zhejiang Univ Sci B;11:647-653.
  200. References Bandres, E., N. Bitarte, F. Arias, J. Agorreta, P. Fortes, X. Agirre, R. Zarate, J. A. Diaz- Gonzalez, N. Ramirez, J. J. Sola, P. Jimenez, J. Rodriguez & J. Garcia-Foncillas (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, Vol.15, pp. 2281-90, ISSN 1078- 0432

200 of 1027 shown

Cited by

See all 4

Metadata

Publisher
InTech
Published
2011-06-15
DOI
10.5772/712
Cited by
4
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastric Carcinoma - Molecular Aspects and Current Advances. https://app.cochat.ai/papers/10.5772/712
The paper
Gastric Carcinoma - Molecular Aspects and Current Advances. (2011). https://doi.org/10.5772/712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.